Changes and risk factors of high-sensitivity troponin I during perioperative hip arthroplasty

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200059360

Enrollment

Unknown

Registered

2022-04-28

Start date

2022-04-20

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury

Interventions

Myocardial injury group:Situation investigation without intervention

Non-myocardial injury group:Situation investigation without intervention

Eligibility

Sex/Gender

All

Age

45 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective unilateral hip arthroplasty who voluntarily participated in the study and signed the informed consent form; 2. Age > 45 years old, no gender restriction; 3. American Society of Anesthesiologists (ASA) I-III grades.

Exclusion criteria

Exclusion criteria: 1. History of severe liver and kidney diseases; 2. Patients with severe cardiovascular and cerebrovascular and heart diseases, and various types of severe arrhythmias; 3. History of malignant tumors; 4. Those with mental and cognitive impairments; 5. Those who refuse to participate or ask to quit midway.

Design outcomes

Primary

Measure	Time frame
High-sensitivity troponin I;	—

Secondary

Measure	Time frame
Gender;Age;Past medical history;Blood pressure;Blood sugar;Blood lipids;ECG;Chest x-ray/chest CT;Type of surgery;Anesthesia;Operation time;Vasoactive drug use;Heart rate;Oxygen saturation;Bleeding;Hemoglobin concentration;Lactic acid concentration;	—

Countries

China

Contacts

Public ContactLiu Danyan

The First Affiliated Hospital of Chongqing Medical UniversityMedical University

Liudanyan418@qq.com+86 13983916178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026